HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Kiguchi Selected Research

Paraproteins

4/2021A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Kiguchi Research Topics

Disease

7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 02/2007
7Neoplasms (Cancer)
06/2022 - 10/2002
5Multiple Myeloma
04/2021 - 04/2019
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2018 - 01/2009
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2022 - 02/2007
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2003 - 10/2002
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 04/2009
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022 - 05/2017
2Lymphoma (Lymphomas)
03/2020 - 10/2002
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 11/2018
1Hematologic Neoplasms (Hematological Malignancy)
06/2022
1Injection Site Reaction
06/2022
1Wilms Tumor (Wilm's Tumor)
06/2022
1Chronic Renal Insufficiency
04/2022
1Residual Neoplasm
04/2021
1Chromosome Aberrations (Chromosome Abnormalities)
12/2020
1Neutropenia
05/2020
1Peripheral Nervous System Diseases (PNS Diseases)
05/2020
1Anemia
05/2020
1Thrombocytopenia (Thrombopenia)
05/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2020
1Multi-centric Castleman's Disease
02/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2018
1Paraproteinemias (Monoclonal Gammopathy)
05/2018
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2017
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017
1Rheumatoid Arthritis
09/2017
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2017
1Disease Progression
09/2017
1Tumor Lysis Syndrome
10/2016
1Hyperuricemia
10/2016
1Neoplasm Metastasis (Metastasis)
11/2012
1Disseminated Intravascular Coagulation
11/2012
1Stomach Neoplasms (Stomach Cancer)
11/2012
1Acute Promyelocytic Leukemia
03/2010
1Hemolysis
02/2010
1Blast Crisis (Blast Phase)
01/2010
1Aplastic Anemia (Anemia, Hypoplastic)
05/2009

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
06/2022 - 07/2003
4Imatinib Mesylate (Gleevec)FDA Link
02/2018 - 01/2009
3Rituximab (Mabthera)FDA Link
05/2022 - 04/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009 - 01/2003
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2003 - 10/2002
2Azacitidine (5 Azacytidine)FDA Link
08/2022 - 05/2022
2Bendamustine HydrochlorideFDA Link
05/2022 - 05/2017
2Biological ProductsIBA
10/2020 - 09/2017
2Bortezomib (Velcade)FDA Link
05/2020 - 08/2019
2plerixaforFDA Link
11/2018 - 11/2018
2Interleukin-8 (Interleukin 8)IBA
11/2003 - 01/2003
1alvocidib (flavopiridol)IBA
06/2022
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2022
1Daunorubicin (Cerubidine)FDA LinkGeneric
06/2022
1Peptides (Polypeptides)IBA
06/2022
1venetoclaxIBA
04/2022
1ParaproteinsIBA
04/2021
1Immunoglobulin G (IgG)IBA
04/2021
1elotuzumabIBA
04/2021
1isatuximabIBA
12/2020
1Proteins (Proteins, Gene)FDA Link
10/2020
1Lenalidomide (CC 5013)FDA Link
05/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2020
1Melphalan (Alkeran)FDA LinkGeneric
05/2020
1Prednisolone (Predate)FDA LinkGeneric
05/2020
1Core Binding Factors (Core-Binding Factor)IBA
01/2020
1Thalidomide (Thalomid)FDA Link
04/2019
1Fibrin Fibrinogen Degradation ProductsIBA
05/2018
1Immunoglobulin M (IgM)IBA
05/2018
1Fibrinogen (Factor I)FDA Link
05/2018
1romidepsin (FK228)FDA Link
11/2017
1Methotrexate (Mexate)FDA LinkGeneric
09/2017
1fludarabineIBA
05/2017
1Uric Acid (Urate)IBA
10/2016
1rasburicase (Elitek)FDA Link
10/2016
1FebuxostatFDA Link
10/2016
1Allopurinol (Remid)FDA LinkGeneric
10/2016
1Xanthine OxidaseIBA
10/2016
1Docetaxel (Taxotere)FDA Link
11/2012
1Dacarbazine (DIC)FDA LinkGeneric
11/2012
1Aligeron (AS 2)IBA
03/2010
1Arsenic Trioxide (Trisenox)FDA Link
03/2010
1Micafungin (FK463)FDA Link
02/2010
1Dasatinib (BMS 354825)FDA Link
01/2010
1Tyrosine Kinase InhibitorsIBA
01/2010
1nilotinibFDA Link
01/2010
1DeferasiroxFDA Link
05/2009
1Chelating AgentsIBA
05/2009

Therapy/Procedure

8Therapeutics
06/2022 - 02/2007
4Drug Therapy (Chemotherapy)
08/2022 - 02/2007
3Transplantation
01/2021 - 01/2010
2Immunotherapy
06/2022 - 04/2021
2Remission Induction
01/2021 - 02/2007
2Stem Cell Transplantation
08/2019 - 01/2010
2Autologous Transplantation
11/2018 - 11/2018
1Aftercare (After-Treatment)
04/2021
1Off-Label Use
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2019
1Plasma Exchange
02/2019
1Biological Therapy
09/2017
1Combination Drug Therapy (Combination Chemotherapy)
11/2012